Titre : Tumeurs hormonodépendantes

Tumeurs hormonodépendantes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Probability
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs hormonodépendantes : Questions médicales les plus fréquentes", "headline": "Tumeurs hormonodépendantes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs hormonodépendantes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-19", "dateModified": "2025-04-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs hormonodépendantes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs", "url": "https://questionsmedicales.fr/mesh/D009369", "about": { "@type": "MedicalCondition", "name": "Tumeurs", "code": { "@type": "MedicalCode", "code": "D009369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04" } } }, "about": { "@type": "MedicalCondition", "name": "Tumeurs hormonodépendantes", "alternateName": "Neoplasms, Hormone-Dependent", "code": { "@type": "MedicalCode", "code": "D009376", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yasuhiro Miki", "url": "https://questionsmedicales.fr/author/Yasuhiro%20Miki", "affiliation": { "@type": "Organization", "name": "Department of Disaster Obstetrics and Gynecology, International Research Institute of Disaster Science (IRIDes), Tohoku University, Sendai, Japan." } }, { "@type": "Person", "name": "Hironobu Sasano", "url": "https://questionsmedicales.fr/author/Hironobu%20Sasano", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan." } }, { "@type": "Person", "name": "Olivier Mansier", "url": "https://questionsmedicales.fr/author/Olivier%20Mansier", "affiliation": { "@type": "Organization", "name": "INSERM U1218, ACTION, Université de Bordeaux, UFR Sciences de la Vie et de la Santé, 33000 Bordeaux, France." } }, { "@type": "Person", "name": "Eric Lippert", "url": "https://questionsmedicales.fr/author/Eric%20Lippert", "affiliation": { "@type": "Organization", "name": "CHRU Brest, Laboratoire d'Hématologie, 29200 Brest, France." } }, { "@type": "Person", "name": "Aleix Prat", "url": "https://questionsmedicales.fr/author/Aleix%20Prat", "affiliation": { "@type": "Organization", "name": "Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain; SOLTI cooperative group, Barcelona, Spain; Institute of Oncology (IOB)-Hospital Quirónsalud, Barcelona, Spain; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA; Department of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: alprat@clinic.cat." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Analysis of Physicians' Probability Estimates of a Medical Outcome Based on a Sequence of Events.", "datePublished": "2022-06-01", "url": "https://questionsmedicales.fr/article/35759260", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2022.18804" } }, { "@type": "ScholarlyArticle", "name": "Machine learning model to estimate probability of remission in patients with idiopathic membranous nephropathy.", "datePublished": "2023-10-30", "url": "https://questionsmedicales.fr/article/37913570", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.intimp.2023.111126" } }, { "@type": "ScholarlyArticle", "name": "A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma.", "datePublished": "2023-07-19", "url": "https://questionsmedicales.fr/article/37478617", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ygyno.2023.06.579" } }, { "@type": "ScholarlyArticle", "name": "Whole Blood Resuscitation and Association with Survival in Injured Patients with an Elevated Probability of Mortality.", "datePublished": "2023-04-11", "url": "https://questionsmedicales.fr/article/37039365", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/XCS.0000000000000708" } }, { "@type": "ScholarlyArticle", "name": "Who did the ACA Medicaid expansion impact? Estimating the probability of being a complier.", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37012649", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/hec.4682" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Tumeurs", "item": "https://questionsmedicales.fr/mesh/D009369" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs hormonodépendantes", "item": "https://questionsmedicales.fr/mesh/D009376" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs hormonodépendantes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs hormonodépendantes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs hormonodépendantes", "description": "Comment diagnostiquer une tumeur hormonodépendante ?\nQuels tests hormonaux sont utilisés ?\nLes marqueurs tumoraux sont-ils utiles ?\nQuelle imagerie est recommandée ?\nLes antécédents familiaux sont-ils pris en compte ?", "url": "https://questionsmedicales.fr/mesh/D009376?mesh_terms=Probability&page=9#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs hormonodépendantes", "description": "Quels sont les symptômes courants ?\nComment les symptômes varient-ils selon le type ?\nLes changements de poids sont-ils un symptôme ?\nLes saignements anormaux sont-ils fréquents ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D009376?mesh_terms=Probability&page=9#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs hormonodépendantes", "description": "Peut-on prévenir les tumeurs hormonodépendantes ?\nLe dépistage est-il recommandé ?\nL'alimentation joue-t-elle un rôle ?\nL'exercice physique est-il bénéfique ?\nLes hormones de substitution sont-elles sûres ?", "url": "https://questionsmedicales.fr/mesh/D009376?mesh_terms=Probability&page=9#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs hormonodépendantes", "description": "Quels traitements sont disponibles ?\nQu'est-ce que l'hormonothérapie ?\nLa chimiothérapie est-elle efficace ?\nLa radiothérapie est-elle courante ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D009376?mesh_terms=Probability&page=9#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs hormonodépendantes", "description": "Quelles complications peuvent survenir ?\nLes métastases sont-elles possibles ?\nLes effets secondaires des traitements sont-ils fréquents ?\nComment gérer la douleur liée aux tumeurs ?\nLes complications psychologiques sont-elles courantes ?", "url": "https://questionsmedicales.fr/mesh/D009376?mesh_terms=Probability&page=9#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs hormonodépendantes", "description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme influence-t-il le risque ?\nL'alimentation affecte-t-elle le risque ?\nLes traitements hormonaux antérieurs sont-ils un risque ?\nL'exposition à des produits chimiques est-elle un facteur ?", "url": "https://questionsmedicales.fr/mesh/D009376?mesh_terms=Probability&page=9#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une tumeur hormonodépendante ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des examens d'imagerie, des biopsies et des tests hormonaux." } }, { "@type": "Question", "name": "Quels tests hormonaux sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests mesurant les niveaux d'œstrogènes, de progestérone ou de testostérone sont effectués." } }, { "@type": "Question", "name": "Les marqueurs tumoraux sont-ils utiles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des marqueurs comme le CA 15-3 ou le PSA peuvent aider au diagnostic." } }, { "@type": "Question", "name": "Quelle imagerie est recommandée ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie, la mammographie ou l'IRM sont souvent utilisées pour visualiser les tumeurs." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils pris en compte ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancers hormonodépendants augmentent le risque." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des masses, des douleurs, des changements hormonaux et des saignements." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon le type ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes dépendent du type de tumeur, par exemple, des douleurs mammaires pour le cancer du sein." } }, { "@type": "Question", "name": "Les changements de poids sont-ils un symptôme ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements de poids peuvent survenir en raison de déséquilibres hormonaux." } }, { "@type": "Question", "name": "Les saignements anormaux sont-ils fréquents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des saignements anormaux peuvent indiquer une tumeur hormonodépendante, surtout gynécologique." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être similaires à ceux d'autres affections, rendant le diagnostic difficile." } }, { "@type": "Question", "name": "Peut-on prévenir les tumeurs hormonodépendantes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures comme un mode de vie sain peuvent réduire le risque, mais pas toutes." } }, { "@type": "Question", "name": "Le dépistage est-il recommandé ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage régulier peut aider à détecter les tumeurs à un stade précoce." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut influencer le risque de développer certaines tumeurs hormonodépendantes." } }, { "@type": "Question", "name": "L'exercice physique est-il bénéfique ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut réduire le risque de certains cancers hormonodépendants." } }, { "@type": "Question", "name": "Les hormones de substitution sont-elles sûres ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent augmenter le risque de certains cancers, nécessitant une évaluation prudente." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la radiothérapie, l'hormonothérapie et la chimiothérapie." } }, { "@type": "Question", "name": "Qu'est-ce que l'hormonothérapie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'hormonothérapie bloque ou modifie l'action des hormones pour ralentir la croissance tumorale." } }, { "@type": "Question", "name": "La chimiothérapie est-elle efficace ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être utilisée pour traiter les tumeurs hormonodépendantes avancées ou récurrentes." } }, { "@type": "Question", "name": "La radiothérapie est-elle courante ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent utilisée pour cibler les tumeurs localisées et réduire leur taille." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont souvent adaptés en fonction du type de tumeur et des hormones impliquées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la propagation de la tumeur, des douleurs chroniques et des effets secondaires des traitements." } }, { "@type": "Question", "name": "Les métastases sont-elles possibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tumeurs hormonodépendantes peuvent se propager à d'autres organes, entraînant des métastases." } }, { "@type": "Question", "name": "Les effets secondaires des traitements sont-ils fréquents ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent provoquer des effets secondaires comme la fatigue, les nausées et des changements hormonaux." } }, { "@type": "Question", "name": "Comment gérer la douleur liée aux tumeurs ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion de la douleur peut inclure des médicaments, des thérapies physiques et des approches complémentaires." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles courantes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'anxiété et la dépression peuvent survenir chez les patients atteints de tumeurs hormonodépendantes." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les antécédents familiaux, l'obésité et l'exposition hormonale." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est associé à un risque accru de plusieurs cancers hormonodépendants." } }, { "@type": "Question", "name": "L'alimentation affecte-t-elle le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées peut augmenter le risque de certains cancers." } }, { "@type": "Question", "name": "Les traitements hormonaux antérieurs sont-ils un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements hormonaux antérieurs peuvent augmenter le risque de développer des tumeurs." } }, { "@type": "Question", "name": "L'exposition à des produits chimiques est-elle un facteur ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certains produits chimiques peut augmenter le risque de cancers hormonodépendants." } } ] } ] }

Sources (2723 au total)

Analysis of Physicians' Probability Estimates of a Medical Outcome Based on a Sequence of Events.

The probability of a conjunction of 2 independent events is the product of the probabilities of the 2 components and therefore cannot exceed the probability of either component; violation of this basi... To ascertain whether physicians are able to correctly estimate the overall probability of a medical outcome resulting from 2 independent events.... This survey study consisted of 3 separate substudies, in which 215 physicians were asked via internet-based survey to estimate the probability of success of each of 2 components of a diagnostic or pro... Case scenarios presented in an online survey.... Respondents were asked to provide their demographic information in addition to 3 probability estimates. The first substudy included a scenario describing a brow presentation discovered during labor; t... Among 215 respondents, the mean (SD) age was 54.0 (9.5) years; 142 respondents (66.0%) were male. Data on race and ethnicity were not collected. A total of 168 physicians (78.1%) estimated the probabi... In this survey study of 215 physicians, respondents consistently overestimated the combined probability of 2 events compared with the probability calculated from their own estimates of the individual ...

Machine learning model to estimate probability of remission in patients with idiopathic membranous nephropathy.

Idiopathic membranous nephropathy (IMN) is a type of nephrotic syndrome and the leading cause of chronic kidney disease. As far as we know, no predictive model for assessing the prognosis of IMN is cu... A total of 266 patients with histopathology-proven IMN were included in this study. Least absolute shrinkage and selection operator regression was utilized to identify the most important variables. Su... A prognostic nomogram was established, which incorporated creatinine, glomerular_basement_membrane_thickening, gender, IgG_deposition, low-density lipoprotein cholesterol, and fibrinogen. The areas un... The nomogram was useful for clinicians to evaluate the prognosis of patients with IMN in early stage....

A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma.

To evaluate clinical, laboratory, and radiological variables from preoperative contrast-enhanced computed tomography (CECT) for their ability to distinguish ovarian clear cell carcinoma (OCCC) from no... This IRB-approved, retrospective study included consecutive patients who underwent surgery for an ovarian tumor from 1/1/2000 to 12/31/2016 and CECT of the abdomen and pelvis ≤90 days before primary d... The final analysis included 533 patients with surgically confirmed OCCC (n = 61) and non-OCCC (n = 472); history of endometriosis was more often found in patients with OCCC (20% versus 3.6%; p < 0.001... A presurgical nomogram model incorporating readily accessible clinical, laboratory, and CECT variables was a powerful predictor of OCCC, a subtype often requiring a distinctive treatment approach....

Whole Blood Resuscitation and Association with Survival in Injured Patients with an Elevated Probability of Mortality.

Low-titer group O whole blood (LTOWB) resuscitation is becoming common in both military and civilian settings and may represent the ideal resuscitation intervention. We sought to characterize the safe... A prospective, multicenter, observational cohort study was performed using 7 trauma centers. Injured patients at risk of massive transfusion who required both blood transfusion and hemorrhage control ... A total of 1,051 patients in hemorrhagic shock met all enrollment criteria. The cohort was severely injured with >70% of patients requiring massive transfusion. After propensity adjustment, no signifi... Early LTOWB resuscitation is safe but not independently associated with survival for the overall enrolled population. When patients were selected with an elevated probability of mortality based on pre...

Context Matters: Emotional Sensitivity to Probabilities and the Bias for Action in Cancer Treatment Decisions.

Past studies have shown a commission bias for cancer treatment, a tendency to choose active treatment even when watchful waiting is less risky. This bias suggests motivations for action beyond mortali... Participants (... We observed a commission bias as in past studies with most participants choosing surgery both when surgery was optimal (71%) and when watchful waiting was optimal (58%). An ESP × Condition interaction... The role of ESP in decision making is context specific. Higher levels of ESP predict choosing action when that action is warranted but do not predict a shift away from surgery when watchful waiting of... Past studies have identified a "commission bias," a tendency to choose active treatment over watchful waiting, even when mortality rate is lower for waiting.Evaluation of risk probabilities is related...

Adjusting conventional FRAX estimates of fracture probability according to the number of prior fractures.

The risk of a recurrent fragility fracture is high following a first fracture and higher still with more than one prior fracture. This study provides adjustments to FRAX-based fracture probabilities a... Prior fractures increase subsequent fracture risk. The aim of this study was to quantify the effect of the number of prior fractures on the 10-year probability of fracture determined with FRAX®.... The study used data from the Reykjavik Study fracture register that documented prospectively all fractures at all skeletal sites in a large sample of the population of Iceland. Ten-year probabilities ... Probability ratios to adjust 10-year FRAX probabilities of a hip fracture and MOF increased with the number of prior fractures but decreased with age in both men and women. Probability ratios were sim... The probability ratios provide adjustments to conventional FRAX estimates of fracture probability according to the number of prior fractures....